Drug Shortage Report for LABETALOL HYDROCHLORIDE INJECTION, USP
Report ID | 78454 |
Drug Identification Number | 02387468 |
Brand name | LABETALOL HYDROCHLORIDE INJECTION, USP |
Common or Proper name | LABETALOL HYDROCHLORIDE INJECTION, USP |
Company Name | MYLAN PHARMACEUTICALS ULC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | LABETALOL HYDROCHLORIDE |
Strength(s) | 5MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS |
Packaging size | 20ML 1VL |
ATC code | C07AG |
ATC description | BETA BLOCKING AGENTS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2018-05-05 |
Estimated end date | Unknown |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2020-04-23 |
Company comments | ID 10718 was resolved in error on Mar-8-2019. Reopened report in this ID. Original 'Actual Start Date' of 2018-05-05 was used. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v2 | 2019-03-13 | French | Compare |
v1 | 2019-03-13 | English | Compare |